Vaginal Mesh Lawsuit

If you need advice because of Vaginal Mesh Side Complications, contact an experienced Vaginal Mesh Lawyer for a free consultation regarding a potential Vaginal Mesh Lawsuit.  These attorneys are pursuing cases for women who reported serious injuries developing from vaginal mesh used in surgeries for treatment of pelvic organ prolapse (POP) and used as a bladder sling for stress urinary incontinence (SUI).   Medical complications from vaginal mesh include:  vaginal mesh erosion, shrinking of the mesh, infection and/or vaginal scarring.

Vaginal Mesh Lawyers are sought after since mesh products are often defective and can erode producing medical complications and pain.  When going up against powerful drug companies, it is best to seek the assistance of a knowledgeable lawyer who can give you professional help in pursuing a Vaginal Mesh Lawsuit.   Vaginal Mesh Lawsuit cases are also occurring in the United Kingdom, Canada and Australia.   Synthetic vaginal mesh is still on the market and used in surgeries every day.  The U.S. Food and Drug Administration (FDA) issued a Safety Communication to inform the public that serious complications associated with surgical mesh for vaginal repair of POP are not rare.  Also, it is not clear that this type of repair is any more effective than the traditional non-mesh repair in patients with POP and even may expose them to greater risk.

Per FDA’s literature, erosion of mesh through the vagina is the most common and consistently reported mesh-related complication from POP surgeries using mesh.  This erosion can end up requiring multiple surgeries to repair and can be debilitating for some women.   In some cases, multiple surgeries will not resolve the complications completely.  Another risk of vaginal POP repair with mesh that has been reported is mesh contraction.  Reports link mesh contraction with vaginal tightening, pain and vaginal shortening.  Both of these issues could lead to severe pelvic pain, painful sexual intercourse and the inability to engage in sex at all.  Men could experience irritation or pain during sexual intercourse if the mesh becomes exposed.  If you or someone you love has suffered from Vaginal Mesh Side Effects, contact a qualified Vaginal Mesh Lawsuit attorney for a free case evaluation.

Current ratings for:
Lymphoma Cells Selectively Destroyed By Experimental Drug Combination

Patient / Public:		1 (1 votes)
Healthcare Prof:

The study, published in the British Journal of Hematology, showed that the experimental drug combination killed cancer cells through a form of cell suicide known as apoptosis, but was relatively non-toxic to normal, healthy cells. Ibrutinib is a new agent that inhibits the B-cell receptor (BCR) signaling complex, which plays an important role in the survival of malignant B-cells. It has shown very promising initial results in the treatment of patients with B-cell malignancies, including chronic lymphocytic leukemia (CLL), DLBCL and MCL. The synergistic interaction of the two drugs proved lethal even to lymphoma cells that had become resistant to bortezomib, when used alone.

"Bortezomib is currently used to treat MCL and multiple myeloma, but, unfortunately, many patients develop resistance to the drug," says the study's principle investigator Steven Grant, M.D., Shirley Carter Olsson and Sture Gordon Olsson Chair in Oncology Research, associate director for translational research, program co-leader of Developmental Therapeutics and Cancer Cell Signaling research member at VCU Massey Cancer Center. "We are hopeful that this combination therapy may circumvent such resistance and eventually help fill an urgent need for more effective therapies for patients with these uncommon blood disorders."

With cultured DLBCL and MCL cells in laboratory experiments spearheaded by Girija Dasmahapatra, Ph.D., lead author of the study's manuscript and instructor in the Department of Internal Medicine at VCU School of Medicine, the scientists found that ibrutinib blocked several molecular pathways that the cancer cells use for growth and survival. When ibrutinib was combined with bortezomib, the scientists observed a high level of synergism between the two drugs that resulted in profound cell death due to DNA damage, culminating in apoptosis. The research findings suggest that the effectiveness of the combination therapy against bortezomib-resistant lymphoma cells may stem from ibrutinib's ability to block signaling pathways used by the cancer cells to survive bortezomib exposure.

Specifically, exposure of DLBCL and MCL cells to ibrutinib blocked the cancer-promoting NF-κB, AKT and ERK1/2 signaling pathways. These signaling pathways provide cells with the ability to adapt to otherwise harmful environmental stimuli by transmitting messages from receptors located at the cell's surface to proteins within the cell that trigger a variety of biological processes. In particular, NF-κB, AKT and ERK1/2 have been shown to carry out many functions that allow cancer cells to survive and proliferate. Significantly, each of these pathways has been implicated in the development of resistance to proteasome inhibitors such as bortezomib.

"We have provided a framework for understanding how an agent like ibrutinib might be employed to enhance the activity of an established anti-cancer agent like bortezomib," says Grant. "We are currently working with representatives from the pharmaceutical industry and the National Cancer Institute to develop a new treatment strategy in which ibrutinib will be combined with proteasome inhibitors like bortezomib for the treatment of patients with lymphomas and potentially other blood cancers."

Current ratings for:
Study Identifies Biomarkers For Early Risk Assessment Of Acute Kidney Injury

Patient / Public:
Healthcare Prof:

"Failure to recognize and manage acute kidney injury in the early stages can lead to devastating outcomes for patients and increased costs to the health care system. Unfortunately, current blood and urine tests are not able to detect it early enough to avoid further complications or provide any chance for intervention," says lead author Kianoush B. Kashani, M.D., a nephrologist and intensivist at Mayo Clinic.

The study's findings give physicians a tool to determine early on whether a patient is at risk, Dr. Kashani says.

Researchers evaluated nearly 340 biomarkers to find the two with the highest correlation to kidney injury risk. The markers, Insulin Growth Factor Binding Protein-7 (IGFBP-7) and Tissue Inhibitor of Metalloproteinases-2 (TIMP-2), were later validated by another multicenter study known as the Sapphire Trial.

Current ratings for:
In Mouse Model Of Schizophrenia, Induction Of Mild Inflammation Leads To Cognitive Deficits

Patient / Public:
Healthcare Prof:

Drs. Tsuyoshi Miyakawa, Keizo Takao, and their colleagues found that Shn-2 deficiency results in mild chronic brain inflammation, which leads to a unique alteration of a specific region in the brain, the dentate gyrus. The "immature Dentate Gyrus (iDG)", as it is referred to by the researchers, is presumed to produce schizophrenia-related phenotypes, such as working memory deficits and impaired nest-building behavior, as reported online in Neuropsychopharmacology.

The transcriptome patterns in the prefrontal cortex of the Shn-2 KO mice and post-mortem schizophrenia patients are surprisingly similar, with 100 commonly altered genes. Interestingly, 11 of the top 20 ranked genes with altered expression levels are involved in inflammatory or immune function. The brains of the mutant mice also exhibit numerous schizophrenia-related phenotypes, including decreased parvalbumin and GAD67 levels, increased theta and decreased gamma power on electroencephalograms, activation of astrocytes, and a thinner cortex.

The researchers also succeeded in rescuing the working memory deficit, impaired nest-building behavior, and some features of iDG in the brain of this schizophrenia model mouse by chronically administering anti-inflammatory drugs. This finding highlights the possibility that genetically-induced changes in the immune system may be a predisposing factor in schizophrenia, providing the groundwork for further studies to elucidate the pathogenesis and pathophysiology of schizophrenia using this model.

Current ratings for:
More Gluten In New Wheat Probably Not Responsible For Increase In Celiac Disease

Patient / Public:
Healthcare Prof:

Donald D. Kasarda cites evidence that the incidence of celiac disease increased during the second half of the 20th century. Some estimates indicate that the disease is 4 times more common today. Also known as gluten intolerance, celiac disease occurs when gluten, a protein in wheat, barley and rye, damages the lining of the small intestine, causing a variety of symptoms. Nobody knows why the disease is increasing. One leading explanation suggests that it results from wheat breeding that led to production of wheat varieties containing higher levels of gluten.

Kasarda's Perspective article examined the scientific evidence for that hypothesis and found that gluten levels in various varieties have changed little on average since the 1920s. Overall gluten consumption, however, has increased due to other factors. One involves increased consumption of a food additive termed "vital gluten," which has tripled since 1977. Vital gluten is a food additive made from wheat flour, and it is added to various food products to improve their characteristics, such as texture. Overall consumption of wheat flour also has increased, so that people in 2000 consumed 2.9 pounds more gluten annually than in 1970, nearly a 25 percent increase.

Current ratings for:
Pathways To Retirement: A Career Stage Analysis Of Retirement Age Expectations

Patient / Public:
Healthcare Prof:

In surveying the literature related to retirement decisions, we found that retirement researchers study primarily the experiences of retirees and older workers, but not the retirement expectations of mid-career workers. Careers researchers, in contrast, tend to study mostly early and mid-career transitions and put less emphasis on late career transitions. To address these blind spots, we integrated careers and retirement research to examine retirement age expectations of professionals at both mid- and late career and determine whether their retirement outlooks differed. We also wanted to find out if different factors predicted retirement outlooks at both of these career stages.

Using a sample of 441 professional workers, we found that those in late career expect to retire three years later than those at mid-career (65 versus 62). HR professional involved in workforce planning may feel reassured that, in the short term, older workers may seek to defer retirement. However, they should be concerned about the expectations of earlier retirement among mid-career professionals, as this may signal acceleration of the anticipated talent crisis.

Contrary to conventional wisdom among HR professionals, we did not find that job satisfaction was related to wanting to delay retirement for mid- or late career managers, thus improving employee job satisfaction will not be particularly helpful in retaining mid- and late career employees. Our findings suggest that enhancing the centrality of work for the employee would be a more actionable lever for delaying retirement, especially for those in late career. Mechanisms for increasing job centrality - thus delaying intentions to retire - include improving job autonomy and interest, task variety, and responsibility.

Retirement involves a set of institutional arrangements combined with socio-cultural meanings to sustain a distinct retirement phase in life course and career pathways. The articles outline that recent forces of change may lead to reinvention of retirement. There are factors that must be recognized as having a significant impact such as the fact that life expectancy and health status of adults over 60 has increased dramatically in recent years. Reinvention could involve change to one or more of the institutional arrangements supporting retirement. New financial risks and uncertainties loom large, as national and corporate pension arrangements are reconfigured to deal with ongoing financial turmoil.

The special issue considers the future of retirement and emphasises that understanding how retirement pathways are changing, and what is influencing them will remain a challenging research task. Institutional changes will be important, but are far from the only influences.

Human Relations, special issue on retirement

Current ratings for:
Childhood Epilepsy In UK Fallen Sharply

Patient / Public:
Healthcare Prof:

Senior author Ruth Gilbert, a professor in the MRC Centre of Epidemiology for Child Health, Institute of Child Health, at University College London, says in a BBC report of the study:

"We're getting better at diagnosing and deciding who should be treated and then there is also probably an effect of factors like fewer cases of meningitis."

Epilepsy is a tendency to have seizures (sometimes called fits) where sudden bursts of excess electrical activity in the brain temporarily disrupt the normal travel of messages between brain cells.

For their study, Gilbert and colleagues examined records from the Health Improvement Network, which furnishes data on a representative sample of about 5% the UK population.

The data they used in their analysis came from records of more than 344,000 children aged 0 to 14 years who had variously been followed from 1994 to 2008.

They found that overall, the number of children diagnosed with epilepsy who were born between 2003 and 2005, was 33% lower than those who were born between 1994 and 1996.

They also found that the annual rate of epilepsy fell by 4% a year between 2001 and 2008, after adjusting for age, gender and deprivation.

When they used a more sensitive indicator for epilepsy, the number of diagnoses fell by 47% and the annual rate fell by 9% per year, for the same periods.

The researchers conclude:

"The decline since the mid-1990s in epilepsy recorded in primary care may be due to more specific diagnosis, cessation of treatment for some forms of epilepsy, reduced exposure to risk factors or all of these factors."

They suggest vaccination against meningitis and reductions in cases of traumatic brain injury in children, both of which are known risk factors for childhood epilepsy, may also partially explain the fall in the figures.

Gilbert says a misdiagnosis of epilepsy can blight a child for life.

But this is less likely to happen nowadays, because the approach is more rigorous, partly as a result of guidelines from the National Institute for Health and Clinical Excellence (NICE).

Nevertheless, Simon Wigglesworth, deputy chief executive at Epilepsy Action, says "epilepsy remains one of the most prevalent neurological conditions in children in the UK."

He says while the study's results may be explained by falling rates of misdiagnoses in children, which they know to be high, they are not convinced it is the whole picture. Doctors tell them they are not seeing falling numbers of children presenting with epilepsy at their surgeries.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Current ratings for:
"Fearless" Patients Terrified By Panic Experiment

Patient / Public:
Healthcare Prof:

Justin Feinstein, of the Departments of Neurology and Psychology at the University of Iowa in the US, and colleagues, write about their findings in the 3 February online issue of Nature Neuroscience.

The Amygdala in the "Fearless" Patient

The condition means she is not afraid of things that strike fear in most people, such as snakes, spiders, horror films, and being attacked at knife or gunpoint.

In December 2010, Feinstein and colleagues reported a study involving SM that they hope will lead to safe and non-invasive ways of diminishing amygdala activity to treat patients with post-traumatic stress disorder (PTSD).

Many studies on animals have shown that the amygdala is crucial for the fear response. Some human studies have also confirmed this.

This has led to the belief, together with the evidence from SM's case, that the amygdala must be the only circuit in the brain that processes events and triggers that evoke fear responses.

Suffocation Experiment

So, if the amygdala is essential for processing events that lead to fear, then people with damaged amygdalas should not get afraid by inhaling CO2.

This was the idea that Feinstein and colleagues wanted to test: especially as inhaling CO2 is a different kind of trigger to sensing external events with eyes and ears.

But when SM underwent an experiment, where she wore a mask to breathe in air enriched with 35% CO2, she had a full blown panic attack. Her body went rigid, her skin was flushed and her eyes opened wide.

The researchers then repeated the experiment with two other female patients with Urbach-Wiethe disease, and 12 healthy controls.

The two brain-damaged patients had the same reaction as SM, and to the researchers' surprise this was much stronger than the fear and panic experienced by the healthy volunteers.

When interviewed after the experiment, all three brain-damaged patients said they were afraid of suffocating and dying when they had the mask on. SM said it was the first time she had felt afraid since being a child.

Feinstein says in a report by Nature News:

"The patients experienced significantly more fear and panic than the controls."

Amygdala May Not Be The Only Circuit for Fear Response

But Feinstein and colleagues propose their findings reveal the amydgala may not be the only circuit for the fear response, or for all fear responses. There may be another circuit for processing events that arise within the body, they say.

Perhaps there is one circuit with the amygdala, for internal events, and another without the amygdala, for external events.

Joseph LeDoux, of New York University, author of "The Emotional Brain" and somewhat of an expert on the amygdala, was not involved in the research. According to Nature News he says:

"This study adds to a growing body of work showing that there are different systems for responses to different kinds of threats."

"There is lots of evidence that the amygdala contributes to threat-evoked responses, but very little evidence that it generates the conscious experience of fear,"he adds.

Christian Jarrett, Editor of the Research Digest Blog for the British Psychological Society, says the study also raises some deep and almost philosophical questions:

"If the amgydala-damaged patients usually live a life that's entirely fear-free, how did they know to describe their feelings during the inhalation as extreme fear or panic? Can we be sure they really felt fear the way that the rest of us do?"

Feinstein is now planning to look for possible non-amygdala brain circuits using brain scans. He anticipates they will find them in the brainstem and the insular cortex, a brain region known to play a part in bodily awareness.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today